Report Detail

Pharma & Healthcare Global G-Protein Coupled Receptor (GPCR) Targeting Market Insights, Forecast to 2025

  • RnM2945300
  • |
  • 14 February, 2019
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein.

The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016.

In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%.

North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%.

Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry.

The global G-Protein Coupled Receptor (GPCR) Targeting market is valued at 79 million US$ in 2018 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 2.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the G-Protein Coupled Receptor (GPCR) Targeting market based on company, product type, end user and key regions.

This report studies the global market size of G-Protein Coupled Receptor (GPCR) Targeting in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of G-Protein Coupled Receptor (GPCR) Targeting in these regions.
This research report categorizes the global G-Protein Coupled Receptor (GPCR) Targeting market by top players/brands, region, type and end user. This report also studies the global G-Protein Coupled Receptor (GPCR) Targeting market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher Scientific
PerkinElmer
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Cisbio
Discoverx
Enzo Life Sciences

Market size by Product
GPCR Consumables
GPCR Equipment
Market size by End User
Oncology
Cardiovascular System
Central Nervous System
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global G-Protein Coupled Receptor (GPCR) Targeting market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of G-Protein Coupled Receptor (GPCR) Targeting market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global G-Protein Coupled Receptor (GPCR) Targeting companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of G-Protein Coupled Receptor (GPCR) Targeting submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of G-Protein Coupled Receptor (GPCR) Targeting are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of G-Protein Coupled Receptor (GPCR) Targeting market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 G-Protein Coupled Receptor (GPCR) Targeting Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth Rate by Product
      • 1.4.2 GPCR Consumables
      • 1.4.3 GPCR Equipment
    • 1.5 Market by End User
      • 1.5.1 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth Rate by End User
      • 1.5.2 Oncology
      • 1.5.3 Cardiovascular System
      • 1.5.4 Central Nervous System
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size
      • 2.1.1 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue 2014-2025
      • 2.1.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales 2014-2025
    • 2.2 G-Protein Coupled Receptor (GPCR) Targeting Growth Rate by Regions
      • 2.2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Regions
      • 2.2.2 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 G-Protein Coupled Receptor (GPCR) Targeting Sales by Manufacturers
      • 3.1.1 G-Protein Coupled Receptor (GPCR) Targeting Sales by Manufacturers
      • 3.1.2 G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Manufacturers
      • 3.1.3 Global G-Protein Coupled Receptor (GPCR) Targeting Market Concentration Ratio (CR5 and HHI)
    • 3.2 G-Protein Coupled Receptor (GPCR) Targeting Revenue by Manufacturers
      • 3.2.1 G-Protein Coupled Receptor (GPCR) Targeting Revenue by Manufacturers (2014-2019)
      • 3.2.2 G-Protein Coupled Receptor (GPCR) Targeting Revenue Share by Manufacturers (2014-2019)
    • 3.3 G-Protein Coupled Receptor (GPCR) Targeting Price by Manufacturers
    • 3.4 G-Protein Coupled Receptor (GPCR) Targeting Manufacturing Base Distribution, Product Types
      • 3.4.1 G-Protein Coupled Receptor (GPCR) Targeting Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers G-Protein Coupled Receptor (GPCR) Targeting Product Type
      • 3.4.3 Date of International Manufacturers Enter into G-Protein Coupled Receptor (GPCR) Targeting Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Product
    • 4.2 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Product
    • 4.3 G-Protein Coupled Receptor (GPCR) Targeting Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global G-Protein Coupled Receptor (GPCR) Targeting Breakdown Data by End User

    6 North America

    • 6.1 North America G-Protein Coupled Receptor (GPCR) Targeting by Countries
      • 6.1.1 North America G-Protein Coupled Receptor (GPCR) Targeting Sales by Countries
      • 6.1.2 North America G-Protein Coupled Receptor (GPCR) Targeting Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America G-Protein Coupled Receptor (GPCR) Targeting by Product
    • 6.3 North America G-Protein Coupled Receptor (GPCR) Targeting by End User

    7 Europe

    • 7.1 Europe G-Protein Coupled Receptor (GPCR) Targeting by Countries
      • 7.1.1 Europe G-Protein Coupled Receptor (GPCR) Targeting Sales by Countries
      • 7.1.2 Europe G-Protein Coupled Receptor (GPCR) Targeting Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe G-Protein Coupled Receptor (GPCR) Targeting by Product
    • 7.3 Europe G-Protein Coupled Receptor (GPCR) Targeting by End User

    8 Asia Pacific

    • 8.1 Asia Pacific G-Protein Coupled Receptor (GPCR) Targeting by Countries
      • 8.1.1 Asia Pacific G-Protein Coupled Receptor (GPCR) Targeting Sales by Countries
      • 8.1.2 Asia Pacific G-Protein Coupled Receptor (GPCR) Targeting Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific G-Protein Coupled Receptor (GPCR) Targeting by Product
    • 8.3 Asia Pacific G-Protein Coupled Receptor (GPCR) Targeting by End User

    9 Central & South America

    • 9.1 Central & South America G-Protein Coupled Receptor (GPCR) Targeting by Countries
      • 9.1.1 Central & South America G-Protein Coupled Receptor (GPCR) Targeting Sales by Countries
      • 9.1.2 Central & South America G-Protein Coupled Receptor (GPCR) Targeting Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America G-Protein Coupled Receptor (GPCR) Targeting by Product
    • 9.3 Central & South America G-Protein Coupled Receptor (GPCR) Targeting by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa G-Protein Coupled Receptor (GPCR) Targeting by Countries
      • 10.1.1 Middle East and Africa G-Protein Coupled Receptor (GPCR) Targeting Sales by Countries
      • 10.1.2 Middle East and Africa G-Protein Coupled Receptor (GPCR) Targeting Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa G-Protein Coupled Receptor (GPCR) Targeting by Product
    • 10.3 Middle East and Africa G-Protein Coupled Receptor (GPCR) Targeting by End User

    11 Company Profiles

    • 11.1 Thermo Fisher Scientific
      • 11.1.1 Thermo Fisher Scientific Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.1.5 Thermo Fisher Scientific Recent Development
    • 11.2 PerkinElmer
      • 11.2.1 PerkinElmer Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.2.5 PerkinElmer Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.3.5 Merck Recent Development
    • 11.4 BD Biosciences
      • 11.4.1 BD Biosciences Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.4.5 BD Biosciences Recent Development
    • 11.5 Molecular Devices
      • 11.5.1 Molecular Devices Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.5.5 Molecular Devices Recent Development
    • 11.6 Promega
      • 11.6.1 Promega Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Promega G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Promega G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.6.5 Promega Recent Development
    • 11.7 Qiagen
      • 11.7.1 Qiagen Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Qiagen G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Qiagen G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.7.5 Qiagen Recent Development
    • 11.8 Abcam
      • 11.8.1 Abcam Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Abcam G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Abcam G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.8.5 Abcam Recent Development
    • 11.9 Corning
      • 11.9.1 Corning Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Corning G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Corning G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.9.5 Corning Recent Development
    • 11.10 Cisbio
      • 11.10.1 Cisbio Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Cisbio G-Protein Coupled Receptor (GPCR) Targeting Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Cisbio G-Protein Coupled Receptor (GPCR) Targeting Products Offered
      • 11.10.5 Cisbio Recent Development
    • 11.11 Discoverx
    • 11.12 Enzo Life Sciences

    12 Future Forecast

    • 12.1 G-Protein Coupled Receptor (GPCR) Targeting Market Forecast by Regions
      • 12.1.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Forecast by Regions 2019-2025
      • 12.1.2 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Forecast by Regions 2019-2025
    • 12.2 G-Protein Coupled Receptor (GPCR) Targeting Market Forecast by Product
      • 12.2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Forecast by Product 2019-2025
      • 12.2.2 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Forecast by Product 2019-2025
    • 12.3 G-Protein Coupled Receptor (GPCR) Targeting Market Forecast by End User
    • 12.4 North America G-Protein Coupled Receptor (GPCR) Targeting Forecast
    • 12.5 Europe G-Protein Coupled Receptor (GPCR) Targeting Forecast
    • 12.6 Asia Pacific G-Protein Coupled Receptor (GPCR) Targeting Forecast
    • 12.7 Central & South America G-Protein Coupled Receptor (GPCR) Targeting Forecast
    • 12.8 Middle East and Africa G-Protein Coupled Receptor (GPCR) Targeting Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 G-Protein Coupled Receptor (GPCR) Targeting Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on G-Protein Coupled Receptor (GPCR) Targeting . Industry analysis & Market Report on G-Protein Coupled Receptor (GPCR) Targeting is a syndicated market report, published as Global G-Protein Coupled Receptor (GPCR) Targeting Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of G-Protein Coupled Receptor (GPCR) Targeting market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,014.70
      4,522.05
      6,029.40
      3,595.80
      5,393.70
      7,191.60
      595,764.00
      893,646.00
      1,191,528.00
      328,029.00
      492,043.50
      656,058.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report